397 related articles for article (PubMed ID: 27099341)
1. Omics Profiling in Precision Oncology.
Yu KH; Snyder M
Mol Cell Proteomics; 2016 Aug; 15(8):2525-36. PubMed ID: 27099341
[TBL] [Abstract][Full Text] [Related]
2. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
3. Patient-specific multi-omics models and the application in personalized combination therapy.
John A; Qin B; Kalari KR; Wang L; Yu J
Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine.
Eke I; Makinde AY; Aryankalayil MJ; Ahmed MM; Coleman CN
Cancer Lett; 2016 Nov; 382(1):118-126. PubMed ID: 26828133
[TBL] [Abstract][Full Text] [Related]
5. The Age of Omics-Driven Precision Medicine.
McColl ER; Asthana R; Paine MF; Piquette-Miller M
Clin Pharmacol Ther; 2019 Sep; 106(3):477-481. PubMed ID: 31407329
[No Abstract] [Full Text] [Related]
6. Preface on application of omics technologies in cancer biology and therapy.
Georgakilas AG
Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
[No Abstract] [Full Text] [Related]
7. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
8. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
9. The systems medicine of neonatal abstinence syndrome.
Stone WL; Wood DL; Justice NA; Shah DS; Olsen ME; Bharti D
Front Biosci (Landmark Ed); 2020 Jan; 25(4):736-759. PubMed ID: 31585915
[TBL] [Abstract][Full Text] [Related]
10. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
Umelo IA; Costanza B; Castronovo V
Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
[TBL] [Abstract][Full Text] [Related]
11. New mass spectrometry technologies contributing towards comprehensive and high throughput omics analyses of single cells.
Couvillion SP; Zhu Y; Nagy G; Adkins JN; Ansong C; Renslow RS; Piehowski PD; Ibrahim YM; Kelly RT; Metz TO
Analyst; 2019 Jan; 144(3):794-807. PubMed ID: 30507980
[TBL] [Abstract][Full Text] [Related]
12. Cancer Omics: Adding Understanding to Knowledge.
Hondermarck H
Proteomics; 2019 Nov; 19(21-22):e1800393. PubMed ID: 31556228
[No Abstract] [Full Text] [Related]
13. Applying Proteomics and Integrative "Omics" Strategies to Decipher the Chronic Kidney Disease-Related Atherosclerosis.
Tracz J; Luczak M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299112
[TBL] [Abstract][Full Text] [Related]
14. Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods.
Kuang Z; Kong M; Yan N; Ma X; Wu M; Li J
Curr Treat Options Oncol; 2024 May; 25(5):679-701. PubMed ID: 38676836
[TBL] [Abstract][Full Text] [Related]
15. Multi-Omics Model Applied to Cancer Genetics.
Pettini F; Visibelli A; Cicaloni V; Iovinelli D; Spiga O
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072237
[TBL] [Abstract][Full Text] [Related]
16. Onco-Multi-OMICS Approach: A New Frontier in Cancer Research.
Chakraborty S; Hosen MI; Ahmed M; Shekhar HU
Biomed Res Int; 2018; 2018():9836256. PubMed ID: 30402498
[TBL] [Abstract][Full Text] [Related]
17. The Omics Revolution Continues: The Maturation of High-Throughput Biological Data Sources.
Mathé E; Hays JL; Stover DG; Chen JL
Yearb Med Inform; 2018 Aug; 27(1):211-222. PubMed ID: 30157526
[TBL] [Abstract][Full Text] [Related]
18. A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research.
Vlachavas EI; Bohn J; Ückert F; Nürnberg S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802234
[TBL] [Abstract][Full Text] [Related]
19. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
[TBL] [Abstract][Full Text] [Related]
20. Knowledge Generation with Rule Induction in Cancer Omics.
Scala G; Federico A; Fortino V; Greco D; Majello B
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
